NYSE:AB
AllianceBernstein Holding LP Stock News
$33.85
-0.110 (-0.324%)
At Close: May 17, 2024
AB Science a reçu les premières autorisations règlementaires pour initier une étude clinique confirmatoire de phase 3 avec le masitinib dans le traitement de la maladie d’Alzheimer
04:04pm, Monday, 10'th Oct 2022 GlobeNewswire Inc.
COMMUNIQUE DE PRESSE
AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer’s disease
04:04pm, Monday, 10'th Oct 2022 GlobeNewswire Inc.
PRESS RELEASE
AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2022 et présente un point sur ses activités
04:39pm, Friday, 30'th Sep 2022 GlobeNewswire Inc.
COMMUNIQUE DE PRESSE
AB Science today reports its revenues for the first half of 2022 and provides an update on its activities
04:39pm, Friday, 30'th Sep 2022 GlobeNewswire Inc.
PRESS RELEASE
These Are 10 Asset Management Companies With A High Payout Ratio
08:50pm, Monday, 26'th Sep 2022
Payout ratio isn't among the top of the list for most investors when they analyze a stock for investment, but it is an important indicator of what stage of business a company is in.
Lazard's (LAZ) August AUM Slips 3.6% on Market Depreciation
03:22pm, Thursday, 15'th Sep 2022 Zacks Investment Research
Market depreciation, unfavorable FX movements and net outflows hurt Lazard's (LAZ) August AUM balance.
AB Science - Recommandation favorable du comité indépendant de revue des données de poursuivre l’étude de Phase 2 évaluant l’activité antivirale du masitinib dans le traitement du Covid-19
04:21pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
COMMUNIQUE DE PRESSE
AB Science - Positive recommendation of the Data and Safety Monitoring Board to continue the Phase 2 study evaluating the antiviral activity of masitinib in Covid-19
04:21pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
PRESS RELEASE
Invesco's (IVZ) August AUM Down on Unfavorable Market Returns
01:54pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Market depreciation, unfavorable FX movements and non-management fee-earning net outflows hurt Invesco's (IVZ) August AUM balance as it falls 2.3% from the prior month.
NVIDIA Draws Attention To Pelosi's Stock Picks
12:00am, Tuesday, 06'th Sep 2022 Investing.com
Meet the Most Trusted Financial companies in 2022, according to MarketWatch, IBD survey
04:45pm, Monday, 29'th Aug 2022 MarketWatch
Investor's Business Daily and MarketWatch join forces to find the 25 Most Trusted Financial Companies in the U.S. Check out the ranking.
IBD's 3rd Annual Customer Trust Survey: Stalwarts And Newcomers Win Praise
07:00am, Monday, 29'th Aug 2022
Customer trust is hard to earn. Amid a tough economy and stock market, a new survey found out which financial firms consumers trust with their money.
AB Science annonce avoir déposé une demande d'autorisation de mise sur le marché conditionnelle auprès de l’EMA pour le masitinib dans le traitement de la SLA
05:07pm, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.
COMMUNIQUE DE PRESSE
AB Science announces that it has filed an application for conditional Marketing Authorization to EMA for masitinib in the treatment of ALS
05:07pm, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.
PRESS RELEASE
AllianceBernstein (AB) Stock Up 2.3% as July AUM Rises 6.5%
10:55am, Friday, 12'th Aug 2022 Zacks Investment Research
Market appreciation and the acquisition of CarVal Investors aid AllianceBernstein's (AB) July AUM balance as it rises 6.5% from the prior month.
